ALS trials
Have you ever considered participating in a clinical trial (study) and thus contributing to medical research?
Clinical trials: between facts and fiction - Click here
What is new in the treatment of ALS? - Click here
Info experimental studies
Clinical trials in Belgium...
PRECISION-ALS Active and recruiting
QRL-201 Active and recruiting
CARDINALS Active but not recruiting
ActiSLA-studie-CHR-Citadelle-Luik Active and recruiting
AP101-studie Active and recruiting
Corcept Therapeutics DAZALS studie met CORT113176 (dazucorilant) Active but not recruiting
Amylyx - Phoenix Completed
Studie met TPN-101 in C9orf72 ALS en/of FTD Active but not recruiting
Wave FOCUS-C9 studie met C9orf72 ASO in ALS en FTD discontinued
HIMALAYA-studie Discontinued
MAGNET-studie Active and recruiting
Cytokinetics COURAGE studie met Reldesemtiv discontinued
Ferrer ADORE studie met FAB122 (orale vorm edaravone) Active but not recruiting
Biogen ATLAS studie met ASO met presymptomatische SOD1 dragers Completed
Ionis FUSION studie met FUS ASO Active and recruiting
Apellis MERIDIAN studie met pegcetacoplan in ALS discontinued
Alexion CHAMPION-ALS studie discontinued
Orphazyme Arimoclomol (ORARIALS-01) fase III studie Completed
Biogen SOD1 ASO Completed
Biogen Methodologie studie Completed
PESA studie Active and recruiting
PYRAMID (Phenotype Research for ALS Modifyer Discovery) studie Active and recruiting
TUDCA studie Completed
Clinical trials abroad in collaboration with the league
| PRODUCT | STUDIE | STATUS | END DATE | RESPONSIBLE FIRM, UNIV, CLINIC OR COUNTRY |
|
Antiretroviral |
X | Recruiting | NINDS, Australia | |
|
Autologe Stamcellen |
X | Recruiting | US, Other countries | |
|
Allogene Stamcellen |
X | Caribbean, universities | ||
|
AP101-02 |
Active Not Recruiting | 01/2025 | AL-S Pharma | |
| ARGX-119 | REALISE | Active Not Recruiting | 1/07/2027 | BE DK FR NL SWE |
| Cannabinoids | EMERALD | Active Not Recruiting | 01/2024 | Australia |
| CU(II)ATSM | Completed | 12/2022 | Coll Med Dev Australia | |
| Dazucorilant | DAZALS | Active Not Recruiting | STOP 18/11/2023 | Corcept Therapeutics |
| Deferiprone | FAIR-ALS II | Active Not Recruiting | 04/2022 | France |
| Fasudil | REAL | Active Not Recruiting | 12/2028 | US, Australia |
| GDNF | Active Not Recruiting | 09/2025 | Cedars Sinai | |
| Healey Platform Trial | HEALEY | Active Not Recruiting | 07/2024 | NEALS |
| Ibudilast (MN-166) | COMBAT-ALS | Recruiting | 12/2026 | MediciNova |
| ION363 fus | FUSION | Recruiting | 03/2028 | Ionis |
| Lithium Magnet | MAGNET | Recruiting | 06/2024 | Tricals |
| Masinitib | Recruiting | 12/2023 | AB Science | |
| Presymptomatic sod1 | ATLAS | Recruiting | 08/2027 ... |
Biogen |
| PrimeC | PARADIGM OLE | Active Not Recruiting | 11/2024 | Neurosense |
| PTC-857 | CARDINALS | Active Not Recruitng | 03/2025 | PTC Therapeutics |
|
Q-cells |
ALTA BOLT | Not Yet Recruiting | 12/2025 | Q Therapeutics |
| QRL-201 | Recruiting | 05/2025 | QurAlis | |
| RNS60 | Not Yet Recruiting | 06/2026 | Italy and US | |
| VRG50635 | Recruiting | 06/2026 | Verge Genomics |
